Geneos Wealth Management Inc. Ligand Pharmaceuticals Inc Transaction History
Geneos Wealth Management Inc.
- $3.92 Billion
- Q2 2025
A detailed history of Geneos Wealth Management Inc. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 119 shares of LGND stock, worth $21,511. This represents 0.0% of its overall portfolio holdings.
Number of Shares
119
Previous 119
-0.0%
Holding current value
$21,511
Previous $12,000
8.33%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding LGND
# of Institutions
291Shares Held
19.5MCall Options Held
9KPut Options Held
0-
Black Rock Inc. New York, NY2.87MShares$519 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$378 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.06MShares$192 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3927KShares$167 Million0.13% of portfolio
-
State Street Corp Boston, MA750KShares$136 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $3.05B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...